2016
DOI: 10.1016/j.yebeh.2015.11.008
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence and correlates of major depressive disorder (MDD) among adolescent patients with epilepsy attending a Nigerian neuropsychiatric hospital

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 50 publications
0
11
0
Order By: Relevance
“…Health care providers have reason to be concerned, given the potential negative impact on the prognosis of patients who delay or interrupt allopathic services. Patients with untreated seizure disorders risk severe brain injury [ 37 ]depression [ 38 ] and increased risk of mortality [ 39 , 40 ], while often being restricted from participating in normal daily activities, including school or employment. Given that capacity to effectively control many seizure disorders exists locally at no cost (specifically treatment for epilepsy), patients seeking traditional treatment for uncontrolled seizure disorders may be delaying effective biomedical treatment.…”
Section: Discussionmentioning
confidence: 99%
“…Health care providers have reason to be concerned, given the potential negative impact on the prognosis of patients who delay or interrupt allopathic services. Patients with untreated seizure disorders risk severe brain injury [ 37 ]depression [ 38 ] and increased risk of mortality [ 39 , 40 ], while often being restricted from participating in normal daily activities, including school or employment. Given that capacity to effectively control many seizure disorders exists locally at no cost (specifically treatment for epilepsy), patients seeking traditional treatment for uncontrolled seizure disorders may be delaying effective biomedical treatment.…”
Section: Discussionmentioning
confidence: 99%
“…The prevalence of MDD in patients with epilepsy has been estimated to be 20-22%, when DSM-IV criteria is used [6,33,34]. MDD prevalence in the general population is estimated around 2.4-3.8% [35].…”
Section: Depressionmentioning
confidence: 99%
“…The most acceptable methods have been patient-reported measures, such as the Morisky Medication Adherence Scales MMAS-4 and MMAS-8 29,3133. Incomplete adherence to treatment has been associated with several clinical and psychosocial determinants.…”
Section: Introductionmentioning
confidence: 99%